139 related articles for article (PubMed ID: 11679439)
1. Acute inhibition of glucose-6-phosphate translocator activity leads to increased de novo lipogenesis and development of hepatic steatosis without affecting VLDL production in rats.
Bandsma RH; Wiegman CH; Herling AW; Burger HJ; ter Harmsel A; Meijer AJ; Romijn JA; Reijngoud DJ; Kuipers F
Diabetes; 2001 Nov; 50(11):2591-7. PubMed ID: 11679439
[TBL] [Abstract][Full Text] [Related]
2. Acute inhibition of hepatic glucose-6-phosphatase does not affect gluconeogenesis but directs gluconeogenic flux toward glycogen in fasted rats. A pharmacological study with the chlorogenic acid derivative S4048.
van Dijk TH; van der Sluijs FH; Wiegman CH; Baller JF; Gustafson LA; Burger HJ; Herling AW; Kuipers F; Meijer AJ; Reijngoud DJ
J Biol Chem; 2001 Jul; 276(28):25727-35. PubMed ID: 11346646
[TBL] [Abstract][Full Text] [Related]
3. Fatty acid and amino acid modulation of glucose cycling in isolated rat hepatocytes.
Gustafson LA; Neeft M; Reijngoud DJ; Kuipers F; Sauerwein HP; Romijn JA; Herling AW; Burger HJ; Meijer AJ
Biochem J; 2001 Sep; 358(Pt 3):665-71. PubMed ID: 11535127
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of hepatic glucose-6-phosphatase-α in patients with hepatic steatosis.
Konopelska S; Kienitz T; Quinkler M
Obesity (Silver Spring); 2011 Dec; 19(12):2322-6. PubMed ID: 21593806
[TBL] [Abstract][Full Text] [Related]
5. Hepatic VLDL production in ob/ob mice is not stimulated by massive de novo lipogenesis but is less sensitive to the suppressive effects of insulin.
Wiegman CH; Bandsma RH; Ouwens M; van der Sluijs FH; Havinga R; Boer T; Reijngoud DJ; Romijn JA; Kuipers F
Diabetes; 2003 May; 52(5):1081-9. PubMed ID: 12716736
[TBL] [Abstract][Full Text] [Related]
6. Sampling the lipogenic hepatic acetyl-CoA pool in vivo in the rat. Comparison of xenobiotic probe to values predicted from isotopomeric distribution in circulating lipids and measurement of lipogenesis and acetyl-CoA dilution.
Hellerstein MK; Wu K; Kaempfer S; Kletke C; Shackleton CH
J Biol Chem; 1991 Jun; 266(17):10912-9. PubMed ID: 2040608
[TBL] [Abstract][Full Text] [Related]
7. Hepatic ChREBP orchestrates intrahepatic carbohydrate metabolism to limit hepatic glucose 6-phosphate and glycogen accumulation in a mouse model for acute Glycogen Storage Disease type Ib.
Krishnamurthy KA; Rutten MGS; Hoogerland JA; van Dijk TH; Bos T; Koehorst M; de Vries MP; Kloosterhuis NJ; Havinga H; Schomakers BV; van Weeghel M; Wolters JC; Bakker BM; Oosterveer MH
Mol Metab; 2024 Jan; 79():101838. PubMed ID: 37995884
[TBL] [Abstract][Full Text] [Related]
8. Interactions between fatty acid synthesis, oxidation, and esterification in the production of triglyceride-rich lipoproteins by the liver.
Fukuda N; Ontko JA
J Lipid Res; 1984 Aug; 25(8):831-42. PubMed ID: 6491528
[TBL] [Abstract][Full Text] [Related]
9. Carbohydrate-response-element-binding protein (ChREBP) and not the liver X receptor α (LXRα) mediates elevated hepatic lipogenic gene expression in a mouse model of glycogen storage disease type 1.
Grefhorst A; Schreurs M; Oosterveer MH; Cortés VA; Havinga R; Herling AW; Reijngoud DJ; Groen AK; Kuipers F
Biochem J; 2010 Dec; 432(2):249-54. PubMed ID: 20854262
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of hepatic glucose 6-phosphatase gene expression in rats treated with an inhibitor of glucose-6-phosphate translocase.
Simon C; Herling AW; Preibisch G; Burger HJ
Arch Biochem Biophys; 2000 Jan; 373(2):418-28. PubMed ID: 10620367
[TBL] [Abstract][Full Text] [Related]
11. Increase in liver cytosolic lipases activities and VLDL-TAG secretion rate do not prevent the non-alcoholic fatty liver disease in cafeteria diet-fed rats.
de Melo AF; Moreira CCL; Sales CF; Rentz T; Raposo HF; Garófalo MAR; Botion LM; Kettelhut IDC; de Oliveira HCF; Chaves VE
Biochimie; 2018 Jul; 150():16-22. PubMed ID: 29705134
[TBL] [Abstract][Full Text] [Related]
12. High fat feeding induces hepatic fatty acid elongation in mice.
Oosterveer MH; van Dijk TH; Tietge UJ; Boer T; Havinga R; Stellaard F; Groen AK; Kuipers F; Reijngoud DJ
PLoS One; 2009 Jun; 4(6):e6066. PubMed ID: 19557132
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor-increased hepatic very-low-density lipoprotein production and increased serum triglyceride levels in diabetic rats.
Feingold KR; Soued M; Adi S; Staprans I; Shigenaga J; Doerrler W; Moser A; Grunfeld C
Diabetes; 1990 Dec; 39(12):1569-74. PubMed ID: 1978829
[TBL] [Abstract][Full Text] [Related]
14. The chloroform extract of Cyclocarya paliurus attenuates high-fat diet induced non-alcoholic hepatic steatosis in Sprague Dawley rats.
Lin Z; Wu ZF; Jiang CH; Zhang QW; Ouyang S; Che CT; Zhang J; Yin ZQ
Phytomedicine; 2016 Nov; 23(12):1475-1483. PubMed ID: 27765368
[TBL] [Abstract][Full Text] [Related]
15. Multiple factors and pathways involved in hepatic very low density lipoprotein-apoB100 overproduction in Otsuka Long-Evans Tokushima Fatty rats.
Qin B; Anderson RA; Kuzuya T; Kitaura Y; Shimomura Y
Atherosclerosis; 2012 Jun; 222(2):409-16. PubMed ID: 22546076
[TBL] [Abstract][Full Text] [Related]
16. GLP-1 Elicits an Intrinsic Gut-Liver Metabolic Signal to Ameliorate Diet-Induced VLDL Overproduction and Insulin Resistance.
Khound R; Taher J; Baker C; Adeli K; Su Q
Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2252-2259. PubMed ID: 29074588
[TBL] [Abstract][Full Text] [Related]
17. Disturbed lipid metabolism in glycogen storage disease type 1.
Bandsma RH; Smit GP; Kuipers F
Eur J Pediatr; 2002 Oct; 161 Suppl 1():S65-9. PubMed ID: 12373575
[TBL] [Abstract][Full Text] [Related]
18. Hepatic secretion of VLDL fatty acids during stimulated lipogenesis in men.
Aarsland A; Wolfe RR
J Lipid Res; 1998 Jun; 39(6):1280-6. PubMed ID: 9643360
[TBL] [Abstract][Full Text] [Related]
19. GLP-2 Dysregulates Hepatic Lipoprotein Metabolism, Inducing Fatty Liver and VLDL Overproduction in Male Hamsters and Mice.
Taher J; Baker C; Alvares D; Ijaz L; Hussain M; Adeli K
Endocrinology; 2018 Sep; 159(9):3340-3350. PubMed ID: 30052880
[TBL] [Abstract][Full Text] [Related]
20. Alterations of carbohydrate and lipid intermediary metabolism during inhibition of glucose-6-phosphatase in rats.
Herling AW; Burger H; Schubert G; Hemmerle H; Schaefer H; Kramer W
Eur J Pharmacol; 1999 Dec; 386(1):75-82. PubMed ID: 10611466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
